RedHill Biopharma Ltd (RDHL) has released an update.
RedHill Biopharma Ltd. has entered into a Securities Purchase Agreement as of March 29, 2024, to issue and sell securities to identified investors. Investors will purchase American Depositary Shares and Warrants, with the intention to use the proceeds for general corporate purposes and working capital. The agreement outlines the terms of sale, issuance, and use of proceeds from the securities.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
